Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

299,942 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized, blind, controlled phase III clinical trial: Assessing the immunogenicity and safety of freeze-dried human rabies vaccine (vero cell) with a 4-dose regimen (2-1-1) in a 10-60 year-old demographic.
Jin F, Zhu L, Wang Y, Qin G, Tian Y, Xie Y, Jin H, Zhang Y, Wang L, Li J, Wu Z, Sheng Y, Shi L, Yang G, Zhao Z, Chen L, Chen P, Jiang Z, Yu J, Gao Z, Li Q, Wu X, Miao L. Jin F, et al. Among authors: wang l, wang y. Vaccine. 2024 Oct 3;42(23):126059. doi: 10.1016/j.vaccine.2024.06.026. Epub 2024 Jun 27. Vaccine. 2024. PMID: 38937182 Free article. Clinical Trial.
A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China.
Li R, Huang L, Li J, Mo Z, He B, Wang Y, Wu X, Minutello M, Guinet-Morlot F, Pichon S. Li R, et al. Among authors: wang y. Vaccine. 2013 Dec 5;31(50):5940-7. doi: 10.1016/j.vaccine.2013.10.043. Epub 2013 Oct 19. Vaccine. 2013. PMID: 24148575 Free article. Clinical Trial.
Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice.
Li X, Wang L, Liu J, Fang E, Liu X, Peng Q, Zhang Z, Li M, Liu X, Wu X, Zhao D, Yang L, Li J, Cao S, Huang Y, Shi L, Xu H, Wang Y, Suo Y, Yue G, Nie J, Huang W, Li W, Li Y. Li X, et al. Among authors: wang l, wang y. Emerg Microbes Infect. 2022 Dec;11(1):1890-1899. doi: 10.1080/22221751.2022.2097479. Emerg Microbes Infect. 2022. PMID: 35775819 Free PMC article.
Heterologous prime-boost immunisation with mRNA- and AdC68-based 2019-nCoV variant vaccines induces broad-spectrum immune responses in mice.
Li X, Liu J, Li W, Peng Q, Li M, Ying Z, Zhang Z, Liu X, Wu X, Zhao D, Yang L, Cao S, Huang Y, Shi L, Xu H, Wang Y, Yue G, Suo Y, Nie J, Huang W, Li J, Li Y. Li X, et al. Among authors: wang y. Front Immunol. 2023 Mar 15;14:1142394. doi: 10.3389/fimmu.2023.1142394. eCollection 2023. Front Immunol. 2023. PMID: 37006275 Free PMC article.
A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10-60 Years Following Essen and Zagreb Vaccination Procedures.
Wu X, Li J, Zhou L, Chen J, Jin Z, Meng Q, Chai J, Gao H, Wang Y, Zhao D, Wu H, Yu J, Chen N, Wang Y, Lin Y, Huang P, Li Y, Zhang Y. Wu X, et al. Among authors: wang y. Vaccines (Basel). 2023 Aug 1;11(8):1311. doi: 10.3390/vaccines11081311. Vaccines (Basel). 2023. PMID: 37631879 Free PMC article.
An mRNA vaccine against rabies provides strong and durable protection in mice.
Li M, Fang E, Wang Y, Shi L, Li J, Peng Q, Li X, Zhao D, Liu X, Liu X, Liu J, Xu H, Wang H, Huang Y, Yang R, Yue G, Suo Y, Wu X, Cao S, Li Y. Li M, et al. Among authors: wang h, wang y. Front Immunol. 2023 Oct 26;14:1288879. doi: 10.3389/fimmu.2023.1288879. eCollection 2023. Front Immunol. 2023. PMID: 37954577 Free PMC article.
Study on immune persistence of the CTN-1V strain rabies vaccine in humans.
Wang L, Li J, Mu Q, Zhu L, Wang Y, Sheng Y, Zhao D, Yang G, Yu X, Wu X, Li Miao. Wang L, et al. Among authors: wang y. J Virus Erad. 2024 Mar 6;10(1):100365. doi: 10.1016/j.jve.2024.100365. eCollection 2024 Mar. J Virus Erad. 2024. PMID: 38590730 Free PMC article.
Corrigendum to "Randomized, blind, controlled phase III clinical trial: Assessing the immunogenicity and safety of freeze-dried human rabies vaccine (vero cell) with a 4-dose regimen (2-1-1) in a 10-60 year-old demographic" [Vaccine (2024) 26059].
Jin F, Zhu L, Wang Y, Qin G, Tian Y, Xie Y, Jin H, Zhang Y, Wang L, Li J, Wu Z, Sheng Y, Shi L, Yang G, Zhao Z, Chen L, Chen P, Jiang Z, Yu J, Gao Z, Li Q, Wu X, Miao L. Jin F, et al. Among authors: wang l, wang y. Vaccine. 2024 Oct 3;42(23):126128. doi: 10.1016/j.vaccine.2024.07.029. Epub 2024 Jul 16. Vaccine. 2024. PMID: 39019659 Free article. No abstract available.
299,942 results
You have reached the last available page of results. Please see the User Guide for more information.